Discontinuation report CIPROFLOXACIN INJECTION

Last updated on 2020-08-17 History
Report ID 120710
Drug Identification Number 02301296
Brand name CIPROFLOXACIN INJECTION
Common or Proper name CIPROFLOXACIN INJECTION
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100mL & 200mL
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for discontinuation Raw material availability
Anticipated discontinuation date 2020-07-31
Actual discontinuation date 2020-07-31
Remaining supply date 2020-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply This product was never marketed by Baxter Corporation. As such, there is no inventory of this product available.
Company comments
Health Canada comments
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-08-17 French Compare
v5 2020-08-17 English Compare
v4 2020-07-21 French Compare
v3 2020-07-21 English Compare
v2 2020-07-21 French Compare
v1 2020-07-21 English Compare